e-learning
resources
Milan 2017
Monday, 11.09.2017
COPD and weaning
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Importance of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in COPD exacerbations
E. Babaoglu (ANKARA, Turkey)
Source:
International Congress 2017 – COPD and weaning
Session:
COPD and weaning
Session type:
Thematic Poster
Number:
2097
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Babaoglu (ANKARA, Turkey). Importance of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in COPD exacerbations. 2097
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018
LSC - 2019 - Assessment of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio as biomarkers of steroid resistance in patients with COPD
Source: International Congress 2019 – Novel molecular pathways in lung cancer and COPD
Year: 2019
Effect of CPAP therapy on neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with obstructive sleep apnea.
Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment
Year: 2017
Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute exacerbation of COPD.
Source: International Congress 2017 – Highlights on clinical problems in COPD
Year: 2017
Could eosinophil / neutrophil ratio be used to determine treatment in COPD patients?
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018
Does the peripheral blood neutrophil lymphocyte ratio increase as the stage of sarcoidosis progresses?
Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Year: 2018
The prognosis of the neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in lung cancer and the association with treatment: a retrospective study>
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017
The meaning of a high monocyte to lymphocyte ratio in tuberculosis
Source: International Congress 2019 – Tuberculosis: diagnosis and scores
Year: 2019
Immunomodulation effect on neutrophil leukocyte and lymphocyte subsets in septic rats
Source: Annual Congress 2010 - Pulmonary infections and sepsis
Year: 2010
Evaluation of neutrophil lymphocyte ratio and C-reactive protein values in the treatment of acute chronic obstructive pulmonary disease exacerbation according to endotype
Source: Virtual Congress 2020 – Monitoring of patients with COPD
Year: 2020
Effect of COPD exacerbations on early lung function decline under maintenance therapy: blood eosinophil count asbiomarker
Source: International Congress 2019 – Eosinophils and FeNO in airway diseases
Year: 2019
Neutrophil to lymphocyte ratio and severity of COPD : prospective study
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021
Stability of blood eosinophilia and neutrophil-to-lymphocyte ratio in COPD
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018
Reproducibility of COPD blood eosinophil counts
Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Year: 2018
Definition of COPD phenotype depending on eosinophil count
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020
The blood eosinophil count as a biomarker in COPD
Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD
Year: 2015
Association between blood eosinophil count and risk of exacerbations in patients with COPD
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017
The reproducibility of COPD blood eosinophil counts
Source: Eur Respir J, 52 (1) 1800427; 10.1183/13993003.00427-2018
Year: 2018
Blood eosinophil count and exacerbation risk in patients with COPD
Source: Eur Respir J, 50 (1) 1700761; 10.1183/13993003.00761-2017
Year: 2017
The eosinophil cationic protein/eosinophil count ratio as a marker of asthma in children
Source: Eur Respir J 2002; 20: Suppl. 38, 114s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept